While there is a plethora of scientific evidence supporting a pathological role of PD-associated mutants of PINK1, DJ-1, and α-synuclein on mitochondrial pathology, several studies have provided evidence that LRRK2 is implicated in regulating oxidative phosphorylation and bioenergetics in different models of PD. This evidence concerns the gene LRRK2 and Parkinson disease.